5-Hydroxytryptamine3 receptor antagonists and cardiac side effects

Louise Brygger, Jørn Herrstedt, Academy of Geriatric Cancer Research (AgeCare)

Research output: Contribution to journalJournal articleResearchpeer-review

Fingerprint

Dive into the research topics of '5-Hydroxytryptamine3 receptor antagonists and cardiac side effects'. Together they form a unique fingerprint.

Medicine & Life Sciences